Gulnihal Ozcan

5PUBLICATIONS
6CO-AUTHORS
Clinical pharmacy and pharmacy practiceMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2025
The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6-step model of rational pharmacotherapy in a Turkish medical school.

Sinem Ezgi Gülmez, Gülnihal Özcan, Hakan S Orer

|Jul 20, 2024
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy.

Ozen Leylek, Megan E Honeywell, Michael J Lee

|Oct 24, 2023
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy.

Ozen Leylek, Megan E Honeywell, Michael J Lee

|Jan 06, 2023
SCUBE2 as a Marker of Resistance to Taxane-based Neoadjuvant Chemotherapy and a Potential Therapeutic Target in Breast Cancer.

Gülnihal Özcan

|Jun 10, 2022
The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer.

Cemre Ucaryilmaz Metin, Gulnihal Ozcan

Pageof 1

Frequent Collaborators

1 joint publications

Ozen Leylek

1 joint publications

Megan E Honeywell

1 joint publications

Michael J Lee

1 joint publications

Michael T Hemann